Effects of enhanced external counterpulsation on skeletal muscle gene expression in patients with severe heart failure

Male patients (n=6, mean age 62 years) with NYHA III-IV and an left ventricular ejection fraction of <35% despite pharmacological therapy received 35 hours of enhanced external counterpulsation (EECP) over a period of 7 weeks.

12

Melin M, Montelius A, Rydén L, Gonon A, Hagerman I, Rullman E